ULBI
Ultralife CorpCompany with tickers: ULBI
CIK
875657
CUSIP
903899102
Shares Outstanding
16,656,669
13F Activity (30d)
47 filings
45 filers
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | $47,445,000 | USD | 2026-03-31 | 10-Q | 2026-05-08 |
| Revenue (ASC 606) | — | ||||
| Cost of Revenue | $37,335,000 | USD | 2026-03-31 | 10-Q | 2026-05-08 |
| Gross Profit | $10,110,000 | USD | 2026-03-31 | 10-Q | 2026-05-08 |
| Operating Expenses | $10,325,000 | USD | 2026-03-31 | 10-Q | 2026-05-08 |
| Research & Development | $2,961,000 | USD | 2026-03-31 | 10-Q | 2026-05-08 |
| Operating Income | $-215,000 | USD | 2026-03-31 | 10-Q | 2026-05-08 |
| Net Income | $-451,000 | USD | 2026-03-31 | 10-Q | 2026-05-08 |
| EPS (Basic) | $-3.00 | USD/shares | 2026-03-31 | 10-Q | 2026-05-08 |
| EPS (Diluted) | $-3.00 | USD/shares | 2026-03-31 | 10-Q | 2026-05-08 |